2017, Stat Pearls, National Center for Biotechnology Information
14 The SAFE Drugs Act 2025 is the New Standard : Expect higher fees, mandatory pre-inspections, and strict interstate reporting
Active cancer, current cancer treatment, or a history of malignancy without oncology sign-off: the peptide works by manipulating p53, and senescence is an anti-tumour brake
Physiological review
Additional randomized controlled trials are needed to clarify the efficacy and safety of SGLT2 inhibitors in the first-line treatment of type 2 diabetes

Well let the digital stacks of research below answer that for you: Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta-Analysis Once-Weekly Semaglutide in Adults with Overweight or Obesity A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder Weight-Loss Drugs Like Ozempic Are Treating Binge Eating, Too Dulaglutide Reduces Binge Eating in Patients With T2D and Binge Eating Disorder Tirzepatide Once Weekly for the Treatment of Obesity Wegovy (semaglutide): a new weight loss drug for chronic weight management Liraglutide for psychiatric disorders: clinical evidence and challenges The use of GLP-1 agonists in the treatment of binge-eating disorder, emotional eating, overweight, and food noise offers much hope and promise to those who have struggled with these debilitating lifelong issues